Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Surg. cosmet. dermatol. (Impr.) ; 14: e20220063, jan.-dez. 2022.
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1369838

ABSTRACT

A sarcoidose é uma doença granulomatosa sistêmica com envolvimento cutâneo em 10 a 25% dos casos. O quadro cutâneo tem sido frequentemente associado a traumas prévios, incluindo o uso de preenchedores cutâneos. Apresenta-se caso de paciente com placa eritematosa em dorso nasal com 12 meses de evolução e histórico de preenchimentos prévios com PMMA e ácido hialurônico. A biópsia cutânea evidenciou processo inflamatório granulomatoso de padrão epitelióide e células gigantes multinucleadas, características de sarcoidose cutânea. As reações granulomatosas tardias podem estar associadas ao uso de preenchedores, tanto pelo trauma provocado pelas cânulas quanto pelos antígenos dos preenchedores utilizados


Sarcoidosis is a systemic granulomatous disease with skin involvement in 10% to 25% of cases. This skin condition has been associated with previous trauma, including the use of skin fillers. We present the case of a patient with an erythematous plaque on the nasal dorsum with 12 months of evolution and a history of previous facial fillings with polymethylmethacrylate and hyaluronic acid. Skin biopsy showed a granulomatous inflammatory process with an epithelioid pattern and multinucleated giant cells, characteristic of cutaneous sarcoidosis. Sarcoidosis can occasionally manifest without systemic involvement and may be associated with the previous use of long-term tissue fillers

2.
Clin. biomed. res ; 42(3): 289-291, 2022.
Article in English | LILACS | ID: biblio-1416959

ABSTRACT

We aim to report a particular case of cutaneous telangiectasias on the arms after immunotherapy with trastuzumab plus paclitaxel to treat breast cancer. New oncology therapies reflect a major advance in cancer treatment. They greatly increase survival; however, they still cause certain adverse cutaneous events that should be taken into account for their proper management.


Subject(s)
Humans , Female , Adult , Telangiectasis/epidemiology , Breast Neoplasms/complications , Trastuzumab/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL